Advertisement
Screener

Tyra Biosciences, Inc. (TYRA) Material Contracts

Tyra Biosciences, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-04: Form 10-Q; Exhibit 10.3; Description Amendment No. 1 to Sales Agreement, dated August 4, 2026, between the Registrant and TD Securities (USA) LLC.
  • 2026-08-04: Form 10-Q; Exhibit 10.2; Description Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Tyra Biosciences, Inc. 2021 Incentive Award Plan.
  • 2026-08-04: Form 10-Q; Exhibit 10.1; Description Non-Employee Director Compensation Program, amended and restated effective May 28, 2026.
  • 2026-03-02: Form 10-K; Exhibit 10.19; Description Second Amendment to Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated December 20, 2022.
FiledFormExhibitDescription
2026-08-0410-Q10.3Amendment No. 1 to Sales Agreement, dated August 4, 2026, between the Registrant and TD Securities (USA) LLC
2026-08-0410-Q10.2Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Tyra Biosciences, Inc. 2021 Incentive Award Plan
2026-08-0410-Q10.1Non-Employee Director Compensation Program, amended and restated effective May 28, 2026
2026-03-0210-K10.19Second Amendment to Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated December 20, 2022
2025-08-1410-Q10.1Non-Employee Director Compensation Program, amended and restated effective May 29, 2025
2024-11-0710-Q10.2Employment Agreement, dated September 9, 2024, between the Registrant and Douglas Warner, M.D.
2024-11-0710-Q10.1Transition Agreement, dated August 3, 2024, between the Registrant and Hiroomi Tada, M.D., Ph.D.
2024-05-0910-Q10.3Non-Employee Director Compensation Program, amended and restated effective May 1, 2024
2024-03-1910-K10.23Third Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated March 18, 2024
2024-02-058-K10.1Securities Purchase Agreement, dated February 1, 2024, by and between Tyra Biosciences, Inc. and each of the purchasers party thereto.
2023-11-0710-Q10.1Non-Employee Director Compensation Program, amended and restated effective August 1, 2023
2023-03-2210-K10.22Second Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated January 6, 2023
2023-03-2210-K10.21First Amendment to Lease, between the Registrant and Fabric 2676 State, LLC, a California limited liability company, dated May 16, 2022
2023-03-2210-K10.19Second Amendment to Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated December 20, 2022
2023-03-2210-K10.16Consulting Agreement, dated January 1, 2023, by and between Esther van den Boom and the Registrant
2023-03-2210-K10.14Employment Letter Agreement, dated December 31, 2022, by and between Alan Fuhrman and the Registrant
2023-03-2210-K10.5Tyra Biosciences, Inc. Annual Bonus Plan
2022-08-0410-Q10.1Employment Letter Agreement, dated May 16, 2022, by and between Ali Fawaz and the Registrant
2022-03-0310-K10.15Office Lease, between the Registrant and Fabric 2676 State Street, LLC, a California limited liability company, dated March 2, 2022
2022-03-0310-K10.14First Amendment to Lease, between the Registrant and Fabric 2656 State, LLC, a California limited liability company, dated March 2, 2022
2022-03-0310-K10.12Employment Letter Agreement, dated August 19, 2021, by and between John Healy and the Registrant

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kardigan, Inc. (KARD)United States$1.346B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Avalyn Pharma Inc. (AVLN)United States$1.267B
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
HARROW, INC. (HROW)United States$1.240B-42.77
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
OMEROS CORP (OMER)United States$1.456B5.50